首页> 中文期刊> 《老年医学与保健》 >益气补肾活血联合噻托溴胺与沙美特罗替卡松对老年稳定期重度COPD临床疗效观察

益气补肾活血联合噻托溴胺与沙美特罗替卡松对老年稳定期重度COPD临床疗效观察

         

摘要

Objective To explore the effect of Yiqi Bushen Huoxue Decoction combined with western medicine inhalation of Tiotropium bromide and Salmeterol fluticasone on the elderly patients with chronic obstructive pulmonary disease (COPD) in stable phase Ⅲ severe degree.Methods 52 cases were randomly divided into two groups:the treatment group inhaled Tiotropium bromide and Salmeterol fluticasone,and given oral Yiqi Bushen Huoxue Decoction,patients in the control group were treated only with the western medicine and compared their dyspnea score and pulmonary function between the two groups before and after treatment.Results After treatment,the two groups of dyspnea score as well as pulmonary function of FEV1,FVC and IC parameters were both improved to some extent compared with that before treatment,and in the treatment group,the dyspnea score and IC index,compared with the control group after treatment,were changed significantly higher.Conclusion Yiqi Bushen Huoxue combined Tiotropium bromide and Salmeterol fluticasone used in severe stable COPD elderly patients demonstrates more advantages in the improvement of dyspnea and lung function compared to simple western medicine treatment.%目的 探讨中医益气补肾活血汤剂联合西医吸入噻托溴胺与沙美特罗替卡松对老年人群稳定期重度慢性阻塞性肺疾病(COPD)患者的治疗作用.方法 52例COPD老年稳定期重度患者随机分成两组:治疗组每天吸人噻托溴胺与沙美特罗替卡松西医治疗,并给予益气补肾活血汤剂内服,对照组为单纯西医治疗,比较两组治疗前后呼吸困难评分及肺功能.结果 两组治疗后呼吸困难评分、肺功能FEV1、FVC及IC参数均较治疗前有所改善,以治疗组在呼吸困难评分及IC指标的改善尤为明显,与对照组治疗后比较差异有统计学意义(P<0.05).结论 益气补肾活血联合噻托溴胺与沙美特罗替卡松对重度稳定期COPD老年患者在改善呼吸困难及肺功能方面较单纯西医治疗更有优势.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号